Alzheimer's disease
Committees Seek Information
The New York Times reports two congressional committees are seeking information about the US Food and Drug Administration's approval of Biogen's Alzheimer's disease treatment.
PNAS Papers Present Analysis of Koala Retrovirus Transmission, Dementia Metabolites, Tree Growth-Defense Trade-Offs
In PNAS this week: koala retrovirus transmission dynamics, metabolites could potentially diagnose or be used to treat different types of dementia, and more.
Manipulation Concerns Raised
Retraction Watch reports that a law firm has brought up concerns with the US Food and Drug Administration of possible data manipulation among a filing for an Alzheimer's disease treatment.
VA Not Covering Alzheimer's Disease Drug
The Wall Street Journal reports the US Department of Veterans Affairs won't cover Biogen's controversial Alzheimer's disease drug.
Review of Approval Process
Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.